AR060493A1 - Derivados de benzodioxano y benzodioxolano. procesos de obtencion. - Google Patents

Derivados de benzodioxano y benzodioxolano. procesos de obtencion.

Info

Publication number
AR060493A1
AR060493A1 ARP070101632A ARP070101632A AR060493A1 AR 060493 A1 AR060493 A1 AR 060493A1 AR P070101632 A ARP070101632 A AR P070101632A AR P070101632 A ARP070101632 A AR P070101632A AR 060493 A1 AR060493 A1 AR 060493A1
Authority
AR
Argentina
Prior art keywords
independently
compound
formula
nhso2r
so2r
Prior art date
Application number
ARP070101632A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38567078&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR060493(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR060493A1 publication Critical patent/AR060493A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

Reivindicacion 1: Un compuesto para preparar un compuesto de formula (1) donde x es 0 a 3; y es 0 a 5; cada R1 es independientemente -R, -Ph, -CN, halogeno, -OR, -C(O)NH2, -C(O)OR, -NHC(O)R, -SO2R, o -NHSO2R; cada R es independientemente H, alifático C1-6 o fluoroalifático C1-6; cada R2 es independientemente -R, -Ph, -CN, halogeno, -OR, -C(O)NH2, -C(O)OR, -NHC(O)R, -SO2R, o -NHSO2R; yPG2 y PG3 son cada uno grupos protectores amino adecuados o uno cualquiera de PG2 o PG3 es H mientras que el otro es un grupo protector amino adecuado o la porcion -N(PG2)(PG3) de formula (1) es azido; que comprende los pasos de (a) proporcionar un compuesto de formula (2) donde x es 0 a 3; y es 0 a 5; cada R1 es independientemente -R, -Ph, -CN, halogeno, -OR, -C(O)NH2, -C(O)OR, -NHC(O)R, -SO2R, o -NHSO2R, cada R es independientemente hidrogeno, alifático C1-6 o fluoroalifático C1-6; cada R2 es independientemente -R, -Ph, CN, halogeno, -OR, -C(O)NH2, -C(O)OR, -NHC(O)R, -SO2R, o -NHSO2R; PG2 y PG3 son cada uno grupos protectores amino adecuados; y LG es un grupo saliente adecuado, y (b) permitir que dicho compuesto de Formula (2) se ciclise para formar un compuesto de Formula (1).
ARP070101632A 2006-04-18 2007-04-17 Derivados de benzodioxano y benzodioxolano. procesos de obtencion. AR060493A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79283006P 2006-04-18 2006-04-18
US85438306P 2006-10-25 2006-10-25

Publications (1)

Publication Number Publication Date
AR060493A1 true AR060493A1 (es) 2008-06-18

Family

ID=38567078

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101632A AR060493A1 (es) 2006-04-18 2007-04-17 Derivados de benzodioxano y benzodioxolano. procesos de obtencion.

Country Status (6)

Country Link
US (1) US20070255065A1 (es)
AR (1) AR060493A1 (es)
CA (1) CA2648612A1 (es)
PE (1) PE20080317A1 (es)
TW (1) TW200808754A (es)
WO (1) WO2007123942A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010011724A (es) * 2008-04-29 2010-11-30 Nsab Af Neurosearch Sweden Ab Moduladores de neurotransmision de dopamina.
JP2011519839A (ja) * 2008-04-29 2011-07-14 エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ ドーパミン神経伝達のモジュレーター
US8492372B2 (en) * 2008-04-29 2013-07-23 Integrated Research Laboratories Sweden Ab Modulators of dopamine neurotransmission
GB201801128D0 (en) * 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2791675B1 (fr) * 1999-03-30 2001-05-04 Synthelabo Derives de n-[2-(4-aminophenyl) ethyl] -2,3-dihydro-1,4- benzodioxinne-2-methanamine, leur preparation et leur application en therapeutique
US6559169B2 (en) * 2001-04-24 2003-05-06 Wyeth Antidepressant azaheterocyclymethyl derivatives of 2,3-dihydro-1,4-benzodioxan
US7041697B2 (en) * 2002-09-12 2006-05-09 Wyeth Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
US7135479B2 (en) * 2002-09-12 2006-11-14 Wyeth Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans
US7153849B2 (en) * 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans
BRPI0610046A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de benzodioxano e benzodioxolano e usos destes
EP1871754A1 (en) * 2005-04-22 2008-01-02 Wyeth a Corporation of the State of Delaware Dihydrobenzofuran derivatives and uses thereof

Also Published As

Publication number Publication date
US20070255065A1 (en) 2007-11-01
WO2007123942A2 (en) 2007-11-01
CA2648612A1 (en) 2007-11-01
PE20080317A1 (es) 2008-06-11
TW200808754A (en) 2008-02-16
WO2007123942A3 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
CR9459A (es) Derivados benzodioxano y benzodioxolano y usos de los mismos
GT200500292A (es) Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR065587A1 (es) Aminoamidas como antagonistas de orexina
TW200718692A (en) Dihydrobenzofuran derivatives and uses thereof
BRPI0510365A (pt) composto, método de produção de um composto, antagonista do receptor nk2, pró-droga, agente farmacêutico, métodos para antagonizar um recpetor nk2 e para evitar ou tratar doenças gastrintestinais funcionais, e, uso do composto ou uma pró-droga do mesmo
UY32463A (es) Derivados de (1-{[5-(4-halo-2-trifluorometil-fenilamino)piridin-2-ilmetil]-carbamoil -ciclopropil)-amidas de ácidos pirimidin-carboxílicos y similares; sus enantiómeros, sus diastereoisómeros, y sus sales, fisiológicamente tolerables.
PA8676301A1 (es) Metodos para sintetizar derivados de 6-alquilaminoquinolina
NO20082136L (no) 1,5-substituerte indol-2-yl-amidderivater
UY29366A1 (es) Derivados de la n-(4,5-difenil-2-tienil)metilamina, su preparacion y su aplicación en terapéutica
AR029301A1 (es) Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos
GT200600030A (es) 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2
AR041297A1 (es) Derivados de 4-pirrolidino- fenil- bencil eter
PE20061362A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como inhibidor de la inflamacion
GT200500317A (es) Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
AR060493A1 (es) Derivados de benzodioxano y benzodioxolano. procesos de obtencion.
AR055420A1 (es) Derivados de pirimidina sustituidos
PE20090110A1 (es) Compuestos macrociclicos derivados de amina como agentes inhibidores de hsp90
RS97004A (en) Benzoxazine derivatives as 5-ht6 modulators and uses thereof
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
PA8575001A1 (es) Fluorobenzamidas como inhibidores de maob
CO2022000422A2 (es) Inhibidores de enzimas
PE20071324A1 (es) Metodos de usar derivados de 3-piridilo como pesticidas
UY29498A1 (es) Derivados de aminoácidos
AR057451A1 (es) Metodos para preparar derivados de acido glutamico

Legal Events

Date Code Title Description
FB Suspension of granting procedure